Last reviewed · How we verify
CEFDITOREN
At a glance
| Generic name | CEFDITOREN |
|---|---|
| Target | Bacterial penicillin-binding protein, Penicillin-binding protein, Penicillin-binding protein 3 |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
Approved indications
- Acute exacerbation of chronic bronchitis
- Bacterial pneumonia
- Haemophilus Influenzae Chronic Bronchitis
- Haemophilus Parainfluenzae Chronic Bronchitis
- Haemophilus Parainfluenzae Pneumonia
- Haemophilus influenzae pneumonia
- Infection due to Staphylococcus aureus
- Moraxella Catarrhalis Chronic Bronchitis
- Moraxella Catarrhalis Pneumonia
- Pneumococcal pneumonia
- Streptococcal tonsillitis
- Streptococcus Pneumoniae Chronic Bronchitis
- Streptococcus pyogenes infection
Common side effects
- Hematuria
- Diarrhea
- Increased urine white blood cells
- Decreased hematocrit
- Increased glucose
- Nausea
- Abnormal dreams
- Allergic reaction
- Anorexia
- Asthenia
- Asthma
- Constipation
Serious adverse events
- Pseudomembranous colitis
- Anaphylaxis
- Stevens-Johnson syndrome
- Toxic epidermal necrolysis
- Hemolytic anemia
- Aplastic anemia
- Renal dysfunction
- Hepatic dysfunction
- Seizures
- Toxic nephropathy
Key clinical trials
- Effectiveness and Safety of Outpatient Treatment of Uncomplicated Acute Diverticulitis Without Antibiotics (NA)
- Pharmacokinetic Study of Cefditoren Pivoxil in Breast Milk and Blood of Lactating Women (NA)
- Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia (PHASE4)
- Study of Cefditoren Pivoxil in Treatment of Childhood With Acute Rhinosinusitis (PHASE4)
- Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CEFDITOREN CI brief — competitive landscape report
- CEFDITOREN updates RSS · CI watch RSS